EVOLVING AZIMUTH IN MUSA CONTEXT
Recruiting · NCT07022067 · Interventional (participants receive a specific treatment) · Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
View the official record on ClinicalTrials.gov →Interventions studied
Telemonitoring app
What this trial is about
Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Have been diagnosed with chronic CS according to the ESC guidelines;
- Over 18 years of age;
- Patients admitted to hospital or with access to first aid within the last year;
- Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
- Wi-Fi or 3G coverage at home;
- Ability to give written informed consent.
Exclusion criteria
- Severe psychiatric disorder
- Inability to use portable technologies
- Patients unable to use the equipment provided
- Patients who deny consent to study participation
Where it is running
1 location listed.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Milan, Italy, Italy